About the Journal

The Colombian Journal of Hematology and Oncology, edited by the Colombian Association of Hematology and Oncology (ACHO), is a peer-reviewed periodical scientific publication, which aims to expand and disseminate knowledge related to hematology, oncology and other areas related. With a biannual periodicity (January-June and July-December) it delivers scientific articles approved by the editorial committee and evaluated by peers to the scientific and academic community.

Presentation

The Colombian Journal of Hematology and Oncology, published by the Colombian Association of Hematology and Oncology (ACHO), is a periodic scientific publication peer-reviewed, aimed at expanding and disseminating knowledge related to hematology, oncology and other related areas. With a 16th-monthly basis (January-June and July-December) it provides the scientific and academic community with scientific articles approved by the editorial committee and evaluated by peers.

Audience

They will be able to publish nurses, general doctors and specialists in the areas of hematology, oncology, pathology and molecular biology, as well as health decision makers, students and members of the academic and scientific community interested in learning and deepening the topics of interest of the journal both nationally and internationally.

Thematic areas

The editorial committee of the Colombian Journal of Hematology and Oncology considers for publication the new knowledge products related to hematology, oncology and other related areas such as molecular mechanisms, epidemiology, clinical characteristics, treatment and interventions in public health of neoplasms and benign haematological conditions.

Publication categories

Publishes original articles, review articles, clinical cases, among others, in Spanish or English language, that meet the characteristics indicated in the instructions to the authors. Preliminary reports (summaries or posters) presented at scientific meetings, or journalistic information of scheduled meetings, will not be accepted.